Find Faculty Members at MUSC.

Onder Albayram Ph.D.

Provider Image
Rank
  • Assistant Professor
College
  • College of Medicine
Department
  • Medicine
Academic Focus
  • Cerebrovascular Diseases
  • Brain–Gut–Microbiota Axis
  • Heart and Brain Aging
Faculty email addresses should not be used to seek medical advice or to make medical appointments. Please visit MyChart for medical appointments or to contact your provider.

Locations

Office Location
street
room

Biography

Dr. Albayram is an Assistant Professor in Medicine in the Department of Medicine, Division of Cardiology and Department of Neuroscience at the Medical University of South Carolina. He is also Affiliated Faculty of the Department of Medicine at Beth Israel Department of Medicine, Harvard Medical School in Boston. In 2009, Dr. Albayram has completed a M.S. in neuropharmacology at the Department of Pharmacological Sciences, University of Southern California in Los Angeles, California. In 2013, he has completed the Ph.D.  in neurobiology at the Institute of Molecular Psychiatry, University of Bonn in Germany. During his PhD, he discovered the novel protective role of the hippocampal endocannabinoid signaling system in brain aging. Dr. Albayram completed his faculty training in Translational Neuroscience perspective at Harvard Medical School. During his time at Harvard Medical School, Dr. Albayram identified the unique cis conformation of tau protein as the early driver of disease in chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI).

 

He is developing an array of diagnostic tools to identify early pathogenic processes and also determine the primary mechanisms of progression of age-related degenerative disorders, like Alzheimer’s disease, chronic cardiovascular disorders. His works were published in prominent journals and highlighted numerous press outlets, including Scientific AmericanGuardianThe ScientistTIME and News Week amongst others.

 

Dr. Albayram’s laboratory focuses on two principal areas: 1) understanding the roles of how endocannabinoid (eCB) signaling controls - and is affected by - normal aging and inflammatory and age-dependent degenerative disorders. 2) understanding the impacts of brain–gut–microbiota axis on cerebrovascular diseases, both age and trauma related.